Contrast-enhanced cardiovascular magnetic resonance imaging of coronary vessel wall: State of art

Expert Review of Cardiovascular Therapy

Volumn 12, Issue 2, 2014, Pages 255-263

  Kuo, Yen Shu ^a   Kelle, Sebastian ^b   Lee, Charlotte ^a   Hinojar, Rocio ^a   Nagel, Eike ^a   Botnar, Rene ^a   Puntmann, Valentina O ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

cardiovascular magnetic resonance; coronary enhancement; coronary wall imaging; gadolinium contrast agent

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

ACUTE CORONARY SYNDROME; AORTA ARCH SYNDROME; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CHRONIC DISEASE; CONTRAST ENHANCEMENT; CORONARY BLOOD VESSEL; HUMAN; IMAGE QUALITY; IMMUNOPATHOLOGY; INFLAMMATION; INFLAMMATORY DISEASE; NONHUMAN; RADIOLOGICAL PARAMETERS; REVIEW; TISSUE SPECIFICITY; VASCULITIS;

ACUTE CORONARY SYNDROME; ANIMALS; CONTRAST MEDIA; CORONARY VESSELS; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; TAKAYASU ARTERITIS; VASCULITIS;

EID: 84893075095     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2014.877838     Document Type: Review

References (58)

1. WHO. World Health Statistics WHO; Geneva, Switzerland: 2008
2. Greenland P, Alpert JS, Beller GA, et al. ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010;122(25): e584-636
3. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by re). Eur Heart J 2012;33(13):1635-701
4. Kragel AH, Reddy SG, Wittes JT, Roberts WC. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. Circulation 1989; 80(6):1747-56
5. Ward MR, Pasterkamp G, Yeung AC, Borst C. Arterial remodeling: mechanisms and clinical implications. Circulation 2000; 102(10):1186-91
6. Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316(22):1371-5
7. Kullo IJ. Vulnerable Plaque: pathobiology and Clinical Implications. Ann Intern Med 1998;129(12):1050
8. Kolodgie FD, Burke AP, Farb A, et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001;16(5):285-92
9. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47(8 Suppl):C13-18
10. Fayad ZA, Fuster V, Fallon JT, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 2000;102(5):506-10
11. Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 2006;114(16):1761-91
12. Macedo R, Chen S, Lai S, et al. MRI detects increased coronary wall thickness in asymptomatic individuals: the multi-ethnic study of atherosclerosis (MESA). J Magn Reson Imaging 2008;28(5):1108-15
13. Miao C, Chen S, Macedo R, et al. Positive remodeling of the coronary arteries detected by magnetic resonance imaging in an asymptomatic population: MESA (Multi- Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2009;53(18):1708-15
14. Botnar RM, Stuber M, Kissinger K V, et al. Noninvasive Coronary Vessel Wall and Plaque Imaging With Magnetic Resonance Imaging. Circulation 2000;102(21):2582-7
15. Kim WY, Astrup AS, Stuber M, et al. Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation 2007;115(2):228-35
16. Kim WY, Stuber M, Bornert P, et al. Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation 2002;106(3): 296-9
17. Gerretsen SC, Kooi ME, Kessels AG, et al. Visualization of coronary wall atherosclerosis in asymptomatic subjects and patients with coronary artery disease using magnetic resonance imaging. PLoS One 2010;5:9
18. Schmidt WA, Nerenheim A, Seipelt E, et al. Diagnosis of early Takayasu arteritis with sonography. Rheumatology (Oxford) 2002;41(5):496-502
19. Bley TA, Uhl M, Carew J, et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol 2007;28(9):1722-7
20. Kerwin WS, O'Brien KD, Ferguson MS, et al. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 2006;241(2): 459-68
21. Maintz D, Ozgun M, Hoffmeier A, et al. Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. Eur Heart J 2006; 27(14):1732-6
22. Yeon SB, Sabir A, Clouse M, et al. Delayed-enhancement cardiovascular magnetic resonance coronary artery wall imaging: comparison with multislice computed tomography and quantitative coronary angiography. J Am Coll Cardiol 2007;50(5):441-7
23. Weiss CR, Arai AE, Bui MN, et al. Arterial wall MRI characteristics are associated with elevated serum markers of inflammation in humans. J Magn Reson Imaging 2001; 14(6):698-704
24. Schmidt WA. Diagnosis of early Takayasu arteritis with sonography. Rheumatology 2002;41(5):496-502
25. Pettigrew RI, Oshinski JN, Chatzimavroudis G, Dixon WT. MRI techniques for cardiovascular imaging. J Magn Reson Imaging 1999;10(5):590-601
26. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001;345(26):1863-9
27. Paetsch I, Jahnke C, Ferrari VA, et al. Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J 2006;27(12):1459-64
28. Ibrahim T, Makowski MR, Jankauskas A, et al. Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. JACC Cardiovasc Imaging 2009;2(5):580-8
29. Kelle S, Schlendorf K, Hirsch GA, et al. Gadolinium enhanced MR Coronary vessel wall imaging at 3.0Tesla. Cardiol Res Pract 2010;2010:856418
30. Puntmann VO, D'Cruz D, Taylor PC, et al. Contrast enhancement imaging in coronary arteries in SLE. JACC Cardiovasc Imaging 2012;5(9):962-4
31. Schneeweis C, Schnackenburg B, Stuber M, et al. Delayed contrast-enhanced MRI of the coronary artery wall in takayasu arteritis. PLoS ONE 2012;7(12):e50655
32. Jansen CHP, Perera D, Makowski MR, et al. Detection of intracoronary thrombus by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 2011;124(4):416-24
33. Madani MH, Canter CE, Balzer DT, et al. Noninvasive detection of transplant coronary artery disease with contrast-enhanced cardiac MRI in pediatric cardiac transplants. J Heart Lung Transplant 2012;31(11):1234-5
34. Hussain T, Fenton M, Peel SA, et al. Detection and grading of coronary allograft vasculopathy in children with contrast-enhanced magnetic resonance imaging of the coronary vessel wall. Circ Cardiovasc Imaging 2013;6(1):91-8
35. Rehwald WG, Fieno DS, Chen E-L, et al. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105(2):224-9
36. Carr DH, Brown J, Bydder GM, et al. Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in patients. AJR Am J Roentgenol 1984; 143(2):215-24
37. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006;47(8 Suppl):C7-12
38. Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation 2008;117(16):2131-41
39. Roman MJ, Shanker B-A, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349(25):2399-406
40. Raman S V, Aneja A, Jarjour WN. CMR in inflammatory vasculitis. J Cardiovasc Magn Reson 2012;14:82
41. Strijkers GJ, Mulder WJM, van Tilborg GAF, Nicolay K. MRI contrast agents: current status and future perspectives. Anticancer Agents Med Chem 2007;7(3):291-305
42. Kalva SP, Blake MA, Sahani DV. MR contrast agents. [Internet]. Applied Radiology; 2006. Available from: www.appliedradiology.com/Issues/2006/01/ Articles/MR-contrast-agents.aspx
43. Makowski MR, Wiethoff AJ, Blume U, et al. Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent. Nat Med 2011; 17(3):383-8
44. Botnar RM, Buecker A, Wiethoff AJ, et al. In vivo magnetic reso1. In vivo magnetic resonance imaging of coronary. Circulation 2004;110(11):1463-6
45. Look DC. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 1970;41(2):250
46. Messroghli DR, Radjenovic A, Kozerke S, et al. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52(1):141-6
47. Botnar RM, Stuber M, Lamerichs R, et al. Initial experiences with in vivo right coronary artery human MR vessel wall imaging at 3 tesla. J Cardiovasc Magn Reson 2003;5(4):589-94
48. Botnar RM, Kim WY, Bornert P, et al. 3D coronary vessel wall imaging utilizing a local inversion technique with spiral image acquisition. Magn Reson Med 2001;46(5): 848-54
49. Bansmann PM, Priest AN, Muellerleile K, et al. MRI of the coronary vessel wall at T: comparison of radial and cartesian k-space sampling. AJR Am J Roentgenol 2007;188(1):70-4
50. Katoh M, Spuentrup E, Buecker A, et al. MRI of coronary vessel walls using radial k-space sampling and steady-state free precession imaging. AJR Am J Roentgenol 2006;186(6 Suppl 2):S401-6
51. Sun J, Zhang Z, Lu B, et al. Identification and quantification of coronary atherosclerotic plaques: a comparison of 64-MDCT and intravascular ultrasound. AJR Am J Roentgenol 2008;190(3):748-54
52. Gerretsen S, Kessels AG, Nelemans PJ, et al. Detection of coronary plaques using MR coronary vessel wall imaging: validation of findings with intravascular ultrasound. Eur Radiol 2013;23(1):115-24
53. Andia ME, Henningsson M, Hussain T, et al. Flow-independent 3D whole-heart vessel wall imaging using an interleaved T2-preparation acquisition. Magn Reson Med 2013;69(1):150-7
54. Li D, Fayad ZA, Bluemke DA. Can contrast-enhanced cardiac magnetic resonance assess inflammation of the coronary wall? JACC Cardiovasc Imaging 2009;2(5):589-91
55. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002; 47(2):372-83
56. Nacif MS, Chugh AR, Lima JAC, Bluemke DA. How should infarct size be measured on LGE sequences? A call for a change in the guidelines. JACC Cardiovasc Imaging 2011;4(11):1223; author reply 1224
57. Pastor A, Voigt T, Schaeffter T, et al. Usefulness of cardiac magnetic resonance in early assessment of cardiomyopathies: myocardial fibrosis is a common denominator. Curr Cardiovasc Imaging Rep 2012;5(2):77-82
58. Puntmann VO, D'Cruz D, Smith Z, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging 2013;6(2):295-301